Zobrazeno 1 - 10
of 873
pro vyhledávání: '"Dominick J Angiolillo"'
Autor:
Nihal El Rouby, Adel Alrwisan, Taimour Langaee, Gloria Lipori, Dominick J Angiolillo, Francesco Franchi, Alberto Riva, Amanda Elsey, Julie A. Johnson, Larisa H. Cavallari, Almut G. Winterstein
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 3, Pp 473-481 (2020)
We aimed to estimate the utility of panel‐based pharmacogenetic testing of patients undergoing percutaneous coronary intervention (PCI). Utilization of Clinical Pharmacogenetic Implementation Consortium (CPIC) level A/B drugs after PCI was estimate
Externí odkaz:
https://doaj.org/article/8f025f716b6344209b03e7a5f3c108c1
Autor:
Luis Ortega-Paz, Victor Arévalos, Diego Fernández-Rodríguez, Víctor Jiménez-Díaz, Jordi Bañeras, Gianluca Campo, Miguel Rodríguez-Santamarta, José Francisco Díaz, Claudia Scardino, Zaira Gómez-Álvarez, Alberto Pernigotti, Fernando Alfonso, Ignacio J Amat-Santos, Antonio Silvestro, Lorenzo Rampa, José M de la Torre Hernández, Gabriela Bastidas, Josep Gómez-Lara, Behnood Bikdeli, Hector M García-García, Dominick J Angiolillo, Josep Rodés-Cabau, Manel Sabaté, Salvatore Brugaletta, CV COVID-19 registry investigators
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0279333 (2022)
BackgroundThe long-term cardiovascular (CV) outcomes of COVID-19 have not been fully explored.MethodsThis was an international, multicenter, retrospective cohort study conducted between February and December 2020. Consecutive patients ≥18 years who
Externí odkaz:
https://doaj.org/article/b97011d860744532bb20db439f9453cf
Autor:
Gabriele Crimi, Alberto Somaschini, Marco Cattaneo, Dominick J Angiolillo, Federico Piscione, Tullio Palmerini, Stefano De Servi
Publikováno v:
Platelets, Vol 29, Iss 3, Pp 309-311 (2018)
Smokers receiving clopidogrel show a lower residual platelet reactivity than non-smokers, a phenomenon generally ascribed to smoking-induced increased production of clopidogrel active metabolite, but also associated with the high hemoglobin levels of
Externí odkaz:
https://doaj.org/article/f639157ba9f945c8b83a439f0e957d67
Diabetes mellitus: a prothrombotic state. Implications for outcomes after coronary revascularization
Autor:
Clarissa Cola, Salvatore Brugaletta, Victoria Martín Yuste, Bieito Campos, Dominick J Angiolillo, Manel Sabaté
Publikováno v:
Vascular Health and Risk Management, Vol 2009, Iss default, Pp 101-119 (2009)
Clarissa Cola1, Salvatore Brugaletta1, Victoria Martín Yuste1, Bieito Campos1, Dominick J Angiolillo2, Manel Sabaté11Interventional Cardiology Unit, Department of Cardiology, Sant Pau University Hospital, Barcelona, Spain; 2Interventional Cardiolog
Externí odkaz:
https://doaj.org/article/0c96dfdbb2c743f88b65373adb93d494
Autor:
Larisa H. Cavallari, Craig R. Lee, Francesco Franchi, Ellen C. Keeley, Joseph S. Rossi, Cameron D. Thomas, Yan Gong, Caitrin W. McDonough, Petr Starostik, Maryam J. Al Saeed, Latonya Been, Natasha Kulick, Jean Malave, Ian R. Mulrenin, Anh B. Nguyen, Joshua N. Terrell, Grace Tillotson, Amber L. Beitelshees, Almut G. Winterstein, George A. Stouffer, Dominick J. Angiolillo
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 8, Pp n/a-n/a (2024)
Abstract Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor (clopidogrel, prasugrel, or ticagrelor) is indicated after percutaneous coronary intervention (PCI) to reduce the risk of atherothrombotic events. Approximately 30%
Externí odkaz:
https://doaj.org/article/7b075fa5eb614f1a8179175d280beddf
Autor:
Kayla R. Tunehag, Cameron D. Thomas, Francesco Franchi, Joseph S. Rossi, Ellen C. Keeley, R. David Anderson, Amber L. Beitelshees, Julio D. Duarte, Yan Gong, Richard A. Kerensky, Caitrin W. McDonough, Anh B. Nguyen, Luis Ortega‐Paz, Sanjay Venkatesh, Yehua Wang, Julie A. Johnson, Almut G. Winterstein, George A. Stouffer, Dominick J. Angiolillo, Larisa H. Cavallari, Craig R. Lee
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 12 (2024)
Background Cytochrome P450 2C19 (CYP2C19) intermediate and poor metabolizer patients exhibit diminished clopidogrel clinical effectiveness after percutaneous coronary intervention (PCI). However, outcome studies to date have lacked racial diversity.
Externí odkaz:
https://doaj.org/article/50016bae702e4bcbb5b7ae35deb0f244
Autor:
Seung-Yul Lee, Jae Young Cho, Diana A. Gorog, Dominick J. Angiolillo, Kyeong Ho Yun, Jong-Hwa Ahn, Jin-Sin Koh, Yongwhi Park, Seok-Jae Hwang, Jin-Yong Hwang, Jin Won Kim, Yangsoo Jang, Young-Hoon Jeong
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundIn patients undergoing percutaneous coronary intervention (PCI), the use of anti-inflammatory therapy with colchicine is associated with a reduction of recurrent ischemic events. The mechanisms of such findings are not fully elucidated.Obje
Externí odkaz:
https://doaj.org/article/9c2a24d63b3b437d9ec7d8a88528312d
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 2, Iss 3 (2023)
A strategy of oral anticoagulants (OAC) in addition to single or dual antiplatelet therapy, known as dual-pathway inhibition (DPI), has shown to reduce thrombotic events in patients with cardiovascular disease. However, despite its efficacy, its use
Externí odkaz:
https://doaj.org/article/23e5f5bc9f5b46628003f203e08f97de
Autor:
Luis Ortega-Paz, Salvatore Giordano, Francesco Franchi, Fabiana Rollini, Charles V. Pollack, Deepak L. Bhatt, Dominick J. Angiolillo
Publikováno v:
Clinical Pharmacokinetics. 62:673-692
Publikováno v:
Trends in Cardiovascular Medicine. 33:133-138
Dual antiplatelet therapy (DAPT) represents the standard of care for patients undergoing percutaneous coronary intervention (PCI). Increasing evidence indicates that a "one-size-fits-all" approach with the use of a standard DAPT regimen for all patie